Which funds hold PBLS?

As of 2026-Q2, 16 institutional funds reported holding PBLS (PARABILIS MEDICINES INC) in SEC 13F filings, with a combined reported value of $430.39M.

How many shares of PBLS do institutions own?

13F filers reported 16.41M shares of PBLS, worth $430.39M in aggregate at the end of 2026-Q2.

Is institutional ownership of PBLS rising or falling?

No prior-quarter baseline is available for a directional read.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Home › Stocks › PBLS

PBLS — PARABILIS MEDICINES INC

Reported value held$430.39M

Funds holding (latest)16

SectorHealth Care

Funds holding (Q2 2026)16

Institutional value$430.39M · 16.41M sh

New / Add / Cut / Exit16 / 0 / 0 / 0

Top-5 / Top-10 concentration94.5% / 99.9%

As of Q2 2026, 16 SEC-registered investment managers reported holding PBLS (PARABILIS MEDICINES INC) in their latest 13F filings, with a combined reported value of $430.39M across 16.41M shares. Ownership is concentrated: the five largest holders account for 94.5% of reported value and the top ten for 99.9%.

Compared with the prior quarter, 16 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

PBLS is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Fund	Quarter	Shares	Value	Portfolio Weight	Change
Fidelity Management & Research (FMR) history	Q2 2026	10.29M	$281.71M	0.01%	New
Farallon Capital Management history	Q2 2026	2.37M	$64.82M	0.30%	New
JPMorgan Chase & Co history	Q2 2026	1.04M	$30.44M	0.00%	New
Casdin Capital history	Q2 2026	645.69K	$17.67M	0.89%	New
Marshall Wace history	Q2 2026	445.36K	$12.19M	0.01%	New
Franklin Resources history	Q2 2026	381.49K	$10.44M	0.00%	New

MFS Investment Management history	Q2 2026	295.96K	$8.10M	0.00%	New
Geode Capital Management history	Q2 2026	99.36K	$2.72M	0.00%	New
UBS Group AG history	Q2 2026	38.70K	$1.06M	0.00%	New
Balyasny Asset Management history	Q2 2026	24.26K	$664.11K	0.00%	New
Two Sigma Investments history	Q2 2026	8.74K	$239.24K	0.00%	New
Goldman Sachs Group history	Q2 2026	8.25K	$225.88K	0.00%	New
Citigroup Inc history	Q2 2026	1.87K	$51.16K	0.00%	New
Wells Fargo & Co history	Q2 2026	1.15K	$31.53K	0.00%	New
T. Rowe Price Associates history	Q2 2026	751.95K	$20.58K	0.00%	New
Morgan Stanley history	Q2 2026	200	$5.47K	0.00%	New

New Positions (Q2 2026)

Fidelity Management & Research (FMR) 10.29M sh · $281.71M
Farallon Capital Management 2.37M sh · $64.82M
JPMorgan Chase & Co 1.04M sh · $30.44M
Casdin Capital 645.69K sh · $17.67M
Marshall Wace 445.36K sh · $12.19M
Franklin Resources 381.49K sh · $10.44M
MFS Investment Management 295.96K sh · $8.10M
Geode Capital Management 99.36K sh · $2.72M
UBS Group AG 38.70K sh · $1.06M
Balyasny Asset Management 24.26K sh · $664.11K
Two Sigma Investments 8.74K sh · $239.24K
Goldman Sachs Group 8.25K sh · $225.88K

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 16 funds)

Fund	Q2 2026
Fidelity Management & Research (FMR)	10.29M
Farallon Capital Management	2.37M
JPMorgan Chase & Co	1.04M
Casdin Capital	645.69K
Marshall Wace	445.36K
Franklin Resources	381.49K
MFS Investment Management	295.96K
Geode Capital Management	99.36K
UBS Group AG	38.70K
Balyasny Asset Management	24.26K
Two Sigma Investments	8.74K
Goldman Sachs Group	8.25K
Citigroup Inc	1.87K
Wells Fargo & Co	1.15K
T. Rowe Price Associates	751.95K
Morgan Stanley	200

Download holders (CSV)